China type 2 diabetes treatment status survey of treatment pattern of oral drugs users

Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy

(2012) J. Rosenstock et al.   DIABETES CARE

Diabetes saps health and wealth from China's rise

(2012) Ted Alcorn et al.   LANCET

Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity

(2012) Wenying Yang et al.   PLoS One

Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs

(2012) Morgan Bron et al.   POSTGRADUATE MEDICINE

Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry

(2012) Diethelm Tschöpe et al.   BMC Endocrine Disorders

Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry

(2011) Anselm K Gitt et al.   European Journal of Preventive Cardiology

Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China

(2010) Zhaolan Liu et al.   Health and Quality of Life Outcomes

Prevalence of Diabetes among Men and Women in China

(2010) Wenying Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys

(2009) Changyu Pan et al.   CURRENT MEDICAL RESEARCH AND OPINION

Changing the Treatment Paradigm for Type 2 Diabetes

(2009) S. Del Prato et al.   DIABETES CARE

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis

(2008) M. Bodmer et al.   DIABETES CARE